The Cooper Companies Reports 6.3% Revenue Growth in Q2 Fiscal 2025

The Cooper Companies, Inc. reported a significant increase in financial performance for the second quarter of fiscal 2025, ending April 30, with net sales reaching $1,002.3 million, a 6.3% increase from $942.6 million in the same period last year. Gross profit also rose to $679.1 million, up from $631.2 million, resulting in a gross margin of 67.7%. Operating income for the quarter was $184.8 million, compared to $161.7 million in the prior year, while net income slightly decreased to $87.7 million from $88.9 million. Earnings per share (EPS) remained stable at $0.44 for both the current and previous year’s quarter.

In the first half of fiscal 2025, total net sales increased to $1,967.0 million from $1,874.2 million, marking a 5% growth. The company attributed this growth to strong performance in both its CooperVision and CooperSurgical segments, with CooperVision net sales rising to $669.6 million, driven by increased demand for toric and multifocal lenses. CooperSurgical also saw a rise in sales, particularly in office and surgical products, which benefited from the acquisition of obp Surgical in August 2024.

The company has made strategic moves to enhance its market position, including several acquisitions. Notably, CooperSurgical acquired obp Surgical for $100 million, which adds a suite of single-use surgical retractors to its portfolio. Additionally, the acquisition of a fertility company specializing in sperm separation devices for $33.5 million and the purchase of Cook Medical assets for $300 million have expanded CooperSurgical's offerings in women's health care. These acquisitions are expected to generate synergies and enhance product offerings in their respective markets.

Operationally, Cooper Companies reported an increase in customer engagement, with a notable rise in the number of contact lens wearers attributed to improved product technology and marketing strategies. The company’s workforce has also expanded, with an increase in employee headcount to support its growing operations. However, the company faced challenges from unfavorable foreign exchange rates, which impacted revenue by approximately $7.7 million in the second quarter. The company continues to focus on geographic expansion, particularly in emerging markets, to further bolster its market share.

Looking ahead, Cooper Companies remains optimistic about the long-term growth prospects in the contact lens and health care markets, despite facing risks from global economic conditions and regulatory changes. The company plans to leverage its recent acquisitions and product innovations to drive future growth, while also managing its debt levels and maintaining compliance with financial covenants. The outlook suggests a commitment to enhancing operational efficiencies and expanding product lines to meet evolving consumer needs.